On Your Mark, Get Set ... Just Kidding

Over-the-counter (OTC) trading is entering its next major evolutionary phase, thanks to the Dodd–Frank Act in the US, and the review of the Markets in Financial Instruments Directive (Mifid II) in Europe, but there are usually two ways to go when it comes to electronic trading: Either it is a race to the bottom, where broker-dealers offer the best priced low-touch access to the market; or the exact opposite, which involves establishing a high-touch relationship with clients.
With OTC trading, it’s usually the latter, given the bespoke nature of the products. But as swap execution facilities (SEFs) trading centrally cleared products are introduced, this will change, and it will become a race to the bottom.
Over the next few years, the market infrastructure will develop. It won’t be a greenfield implementation, since most of the links between dealers and prospective SEF operators, clearinghouses and trade repositories already exist. It is only a matter of testing the trading platforms and configuring the back-office connections. That is an extreme over-simplification, but it should be a straightforward project for SEF-traded instruments once the OTC trading community has clear guidance from the regulators about the new rules.
That's the rub: The US Commodity Futures Trading Commission (CFTC) already kicked the can down the road when it put in a "temporary" measure to extend Dodd–Frank rulemaking until December 31. Everyone knew this extension was coming, given the regulator's near-perfect track record of missing rule-creation deadlines throughout the first half of this year.
I know some major dealers are hoping that with an extension, cooler heads will prevail, since Dodd–Frank was conceived and enacted on the heels of the 2008 credit crisis. The likelihood of this is lessened, however, since the new rules are set to take effect in the months leading up to the 2012 US presidential election, when the national debate is sure to be anything but calm and reasoned. Securing guidance from the regulators during this period will get harder, not easier.
Eventually, firms will need to lace up their cleats for the coming race to the bottom. But for now, the racers haven't left the house to head to the track.
More on Regulation
Doing a deal? Prioritize info security early
Engaging information security teams early in licensing deals can deliver better results and catch potential issues. Neglecting them can cause delays and disruption, writes Devexperts’ Heetesh Rawal in this op-ed.
SEC pulls rulemaking proposals in bid for course correction
The regulator withdrew 14 Gensler-era proposals, including the controversial predictive data analytics proposal.
Trading venues seen as easiest targets for Esma supervision
Platforms do not pose systemic risks for member states and are already subject to consistent rules.
The Consolidated Audit Trail faces an uncertain fate—yet again
Waters Wrap: The CAT is up and running, but with a conservative SEC in place and renewed pressure from politicians and exchanges, Anthony says the controversial database faces a death by a thousand cuts.
Exchanges plead with SEC to trim CAT reporting requirements
Letters from Cboe, Nasdaq and NYSE ask that the new Atkins administration reduce the amount of data required for the Consolidated Audit Trail, and scrap options data collection entirely.
EU banks want the cloud closer to home amid tariff wars
Fears over US executive orders have prompted new approaches to critical third-party risk management.
Friendly fire? Nasdaq squeezes MTF competitors with steep fee increase
The stock exchange almost tripled the prices of some datasets for multilateral trading facilities, with sources saying the move is the latest effort by exchanges to offset declining trading revenues.
Europe is counting its vendors—and souring on US tech
Under DORA, every financial company with business in the EU must report use of their critical vendors. Deadlines vary, but the message doesn’t: The EU is taking stock of technology dependencies, especially upon US providers.